Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

MIRM US Equity

Mirum Pharmaceuticals, Inc.Health Care · Pharmaceutical Preparations · CIK 1759425 · FY ends Dec 31
$97.07
-5.17 (-5.06%)
USD · as of 2026-08-20 · marketstack
15 8-K filings · 2 13D · 9 13G
DateEventWhat happened / filerSource
2026-08-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Janus Henderson Group Ltd.sec.gov ↗
2026-08-0613GSchedule 13G filed — ≥5% beneficial owner (passive) · by FMR LLCsec.gov ↗
2026-08-058-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-06-188-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-05-188-K 8.01Other eventssec.gov ↗
2026-05-188-K 3.02Unregistered sales of equity securitiessec.gov ↗
2026-05-188-K 2.03Creation of a direct financial obligationsec.gov ↗
2026-05-188-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-05-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-05-048-K 8.01Other eventssec.gov ↗
2026-04-2713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-04-278-K 8.01Other eventssec.gov ↗
2026-04-088-K 9.01Financial statements and exhibits (amendment)sec.gov ↗
2026-03-2713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2026-02-258-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-02-1713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by JANUS HENDERSON GROUP PLCsec.gov ↗
2026-02-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by EVENTIDE ASSET MANAGEMENT, LLCsec.gov ↗
2026-01-2713D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by Frazier Life Sciences IX, L.P.sec.gov ↗
2026-01-268-K 8.01Other eventssec.gov ↗
2026-01-268-K 7.01Regulation FD disclosuresec.gov ↗
2026-01-268-K 2.01Completion of acquisition or disposition of assetssec.gov ↗
2026-01-128-K 7.01Regulation FD disclosuresec.gov ↗
2026-01-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-12-198-K 8.01Other eventssec.gov ↗
2025-12-198-K 7.01Regulation FD disclosuresec.gov ↗
2025-12-198-K 3.02Unregistered sales of equity securitiessec.gov ↗
2025-12-198-K 1.01Entry into a material definitive agreementsec.gov ↗
2025-12-088-K 8.01Other eventssec.gov ↗
2025-12-088-K 7.01Regulation FD disclosuresec.gov ↗
2025-12-088-K 3.02Unregistered sales of equity securitiessec.gov ↗
2025-12-088-K 1.01Entry into a material definitive agreementsec.gov ↗
2025-12-0513G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by JANUS HENDERSON GROUP PLCsec.gov ↗
2025-11-178-K 8.01Other eventssec.gov ↗
2025-11-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BIOTECHNOLOGY VALUE FUND L Psec.gov ↗
2025-11-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by JANUS HENDERSON GROUP PLCsec.gov ↗
2025-11-0413D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by Frazier Life Sciences IX, L.P.sec.gov ↗
2025-11-048-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-11-04

Every row is a filed document, checked against its EDGAR index.